References
1. Fung S, Choi H, Gehring A, Janssen H. Getting to HBV cure: The
promising paths forward. Hepatology (Baltimore, Md).2022;76(1):233-250.
2. Global prevalence, treatment, and prevention of hepatitis B virus
infection in 2016: a modelling study. The lancet Gastroenterology
& hepatology. 2018;3(6):383-403.
3. Lai C, Shouval D, Lok A, et al. Entecavir versus lamivudine for
patients with HBeAg-negative chronic hepatitis B. The New England
journal of medicine. 2006;354(10):1011-1020.
4. Marcellin P, Heathcote E, Buti M, et al. Tenofovir disoproxil
fumarate versus adefovir dipivoxil for chronic hepatitis B. The
New England journal of medicine. 2008;359(23):2442-2455.
5. Chang T, Lai C, Kew Yoon S, et al. Entecavir treatment for up to 5
years in patients with hepatitis B e antigen-positive chronic hepatitis
B. Hepatology (Baltimore, Md). 2010;51(2):422-430.
6. Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during
treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a
5-year open-label follow-up study. Lancet (London, England).2013;381(9865):468-475.
7. Lim Y, Gwak G, Choi J, et al. Monotherapy with tenofovir disoproxil
fumarate for adefovir-resistant vs. entecavir-resistant chronic
hepatitis B: A 5-year clinical trial. Journal of hepatology.2019;71(1):35-44.
8. Jacobson I, Washington M, Buti M, et al. Factors Associated With
Persistent Increase in Level of Alanine Aminotransferase in Patients
With Chronic Hepatitis B Receiving Oral Antiviral Therapy.Clinical gastroenterology and hepatology : the official clinical
practice journal of the American Gastroenterological Association.2017;15(7):1087-1094.e1082.
9. Wang K, Lin W, Kuang Z, et al. Longitudinal Change of Body Mass Index
Is Associated With Alanine Aminotransferase Elevation After Complete
Viral Suppression in Chronic Hepatitis B Patients. The Journal of
infectious diseases. 2019;220(9):1469-1476.
10. Lin C, Liao L, Liu C, et al. Hepatitis B viral factors in
HBeAg-negative carriers with persistently normal serum alanine
aminotransferase levels. Hepatology (Baltimore, Md).2007;45(5):1193-1198.
11. Chen C, Lee W, Yang H, et al. Changes in serum levels of HBV DNA and
alanine aminotransferase determine risk for hepatocellular carcinoma.Gastroenterology. 2011;141(4):1240-1248, 1248.e1241-1242.
12. Kim S, Lee Y, Bang S, et al. Early Normalization of Alanine
Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular
Carcinoma in HBV Patients. Journal of clinical medicine.2021;10(9).
13. Wong G, Chan H, Tse Y, et al. Normal on-treatment ALT during
antiviral treatment is associated with a lower risk of hepatic events in
patients with chronic hepatitis B. Journal of hepatology.2018;69(4):793-802.
14. Terrault N, Lok A, McMahon B, et al. Update on prevention,
diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B
guidance. Hepatology (Baltimore, Md). 2018;67(4):1560-1599.
15. Ghany M, Feld J, Chang K, et al. Serum alanine aminotransferase
flares in chronic hepatitis B infection: the good and the bad. The
lancet Gastroenterology & hepatology. 2020;5(4):406-417.
16. Khalili M, Shuhart M, Lombardero M, et al. Relationship Between
Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease
Severity in a Multiethnic North American Cohort With Chronic Hepatitis
B. Diabetes care. 2018;41(6):1251-1259.
17. Demir K, Akyuz F, Ozdil S, et al. What is the reason of elevated
alanine aminotransferase level in HBeAg negative patients with low
viremia: NAFLD or chronic hepatitis? Annals of hepatology.2007;6(2):92-96.
18. Spradling P, Bulkow L, Teshale E, et al. Prevalence and causes of
elevated serum aminotransferase levels in a population-based cohort of
persons with chronic hepatitis B virus infection. Journal of
hepatology. 2014;61(4):785-791.
19. Tang J, Xiong K, Zhang T, Han Han. Application of Metabolomics in
Diagnosis and Treatment of Chronic Liver Diseases. Critical
reviews in analytical chemistry. 2022;52(5):906-916.
20. Li R, Xie L, Li L, et al. viaThe gut microbial metabolite,
3,4-dihydroxyphenylpropionic acid, alleviates hepatic
ischemia/reperfusion injury mitigation of macrophage pro-inflammatory
activity in mice. Acta pharmaceutica Sinica B.2022;12(1):182-196.
21. Clemens M, Kennon-McGill S, Vazquez J, et al. Exogenous phosphatidic
acid reduces acetaminophen-induced liver injury in mice by activating
hepatic interleukin-6 signaling through inter-organ crosstalk.Acta pharmaceutica Sinica B. 2021;11(12):3836-3846.
22. Yang M, Qi X, Li N, et al. Western diet contributes to the
pathogenesis of non-alcoholic steatohepatitis in male mice via
remodeling gut microbiota and increasing production of 2-oleoylglycerol.Nature communications. 2023;14(1):228.
23. Huang H, Sun Z, Pan H, et al. Serum metabolomic signatures
discriminate early liver inflammation and fibrosis stages in patients
with chronic hepatitis B. Scientific reports. 2016;6:30853.
24. Nguyen H, Wimmer R, Le V, Krarup H. Metabolic fingerprint of
progression of chronic hepatitis B: changes in the metabolome and novel
diagnostic possibilities. Metabolomics : Official journal of the
Metabolomic Society. 2021;17(2):16.
25. Cai F, Song Y, Lu Y, Zhang Y, Hu Y, Su S. Analysis of plasma
metabolic profile, characteristics and enzymes in the progression from
chronic hepatitis B to hepatocellular carcinoma. Aging.2020;12(14):14949-14965.
26. Fan R, Papatheodoridis G, Sun J, et al. aMAP risk score predicts
hepatocellular carcinoma development in patients with chronic hepatitis.Journal of hepatology. 2020;73(6):1368-1378.
27. Chen W, Gong L, Guo Z, et al. A novel integrated method for
large-scale detection, identification, and quantification of widely
targeted metabolites: application in the study of rice metabolomics.Molecular plant. 2013;6(6):1769-1780.
28. Zhu Q, Qin M, Wang Z, et al. Plasma metabolomics provides new
insights into the relationship between metabolites and outcomes and left
ventricular remodeling of coronary artery disease. Cell &
bioscience. 2022;12(1):173.
29. Senior J. Alanine aminotransferase: a clinical and regulatory tool
for detecting liver injury-past, present, and future. Clinical
pharmacology and therapeutics. 2012;92(3):332-339.
30. Yuen M, Yuan H, Wong D, et al. Prognostic determinants for chronic
hepatitis B in Asians: therapeutic implications. Gut.2005;54(11):1610-1614.
31. Tsang P, Trinh H, Garcia R, et al. Significant prevalence of
histologic disease in patients with chronic hepatitis B and mildly
elevated serum alanine aminotransferase levels. Clinical
gastroenterology and hepatology : the official clinical practice journal
of the American Gastroenterological Association. 2008;6(5):569-574.
32. Rajcic D, Baumann A, Hernández-Arriaga A, et al. Citrulline
supplementation attenuates the development of non-alcoholic
steatohepatitis in female mice through mechanisms involving intestinal
arginase. Redox biology. 2021;41:101879.
33. Rom O, Liu Y, Liu Z, et al. Glycine-based treatment ameliorates
NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the
gut microbiome. Science translational medicine. 2020;12(572).
34. Stegink L, Filer L, Baker G. Plasma methionine levels in normal
adult subjects after oral loading with L-methionine and
N-acetyl-L-methionine. The Journal of nutrition.1980;110(1):42-49.
35. Liang S, Wei Z, Wu J, Dong X, Liu J, Wang D. Effect of
N-acetyl-l-methionine supplementation on lactation performance and
plasma variables in mid-lactating dairy cows. Journal of dairy
science. 2019;102(6):5182-5190.
36. Kouno Y, Anraku M, Yamasaki K, et al. N-acetyl-L-methionine is a
superior protectant of human serum albumin against post-translational
oxidation as compared to N-acetyl-L-tryptophan. Biochemistry and
biophysics reports. 2016;6:266-274.
37. Martínez-López S, Sarriá B, Baeza G, Mateos R, Bravo-Clemente L.
Pharmacokinetics of caffeine and its metabolites in plasma and urine
after consuming a soluble green/roasted coffee blend by healthy
subjects. Food research international (Ottawa, Ont).2014;64:125-133.
38. Liu D, Xie F, Zeng N, et al. Urine caffeine metabolites are
positively associated with cognitive performance in older adults: An
analysis of US National Health and Nutrition Examination Survey (NHANES)
2011 to 2014. Nutrition research (New York, NY). 2023;109:12-25.
39. Nehlig A. Interindividual Differences in Caffeine Metabolism and
Factors Driving Caffeine Consumption. Pharmacological reviews.2018;70(2):384-411.
40. Jacobson K, Merighi S, Varani K, et al. A Adenosine Receptors as
Modulators of Inflammation: From Medicinal Chemistry to Therapy.Medicinal research reviews. 2018;38(4):1031-1072.
41. Haskó G, Csóka B, Németh Z, Vizi E, Pacher P. A(2B) adenosine
receptors in immunity and inflammation. Trends in immunology.2009;30(6):263-270.
42. Chiu C, Chen C, Cheng M, Pao L, Wang C, Wan G. Use of urinary
hippuric acid and o-/p-/m-methyl hippuric acid to evaluate surgical
smoke exposure in operating room healthcare personnel.Ecotoxicology and environmental safety. 2021;217:112231.
43. Langman J. Xylene: its toxicity, measurement of exposure levels,
absorption, metabolism and clearance. Pathology.1994;26(3):301-309.
44. Shan X, Zhang L, Ye H, et al. Analytical techniques for monitoring
of toluene and xylene exposure biomarkers hippuric acid and
methylhippuric acid in human urine samples. Bioanalysis.2021;13(20):1569-1584.
45. Ketan V, Bhavyata K, Linzbuoy G, Hyacinth H. Renal and hepatotoxic
alterations in adult mice on inhalation of specific mixture of organic
solvents. Toxicology and industrial health.2015;31(12):1158-1164.
46. Kanter M. Protective effect of quercetin on liver damage induced by
chronic toluene exposure in rats. Toxicology and industrial
health. 2012;28(6):483-491.
Table 1. Baseline characteristics of
participants†